DHR:NYE-Danaher Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 190.47

Change

+1.46 (+0.77)%

Market Cap

USD 54.15B

Volume

2.81M

Analyst Target

USD 220.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Danaher Corp designs, manufactures & markets professional, medical, industrial & commercial products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
A Agilent Technologies Inc

-1.36 (-1.20%)

USD 32.44B
IQV IQVIA Holdings Inc

-0.69 (-0.49%)

USD 24.71B
LH Laboratory Corporation of Amer..

+2.22 (+0.90%)

USD 20.88B
DGX Quest Diagnostics Incorporated

+1.34 (+0.78%)

USD 19.12B
QGEN Qiagen NV

+0.13 (+0.29%)

USD 9.05B
CRL Charles River Laboratories

-2.07 (-1.50%)

USD 6.92B
ENZ Enzo Biochem Inc

N/A

USD 0.02B
STRRP Star Equity Holdings Prf

N/A

N/A
TMO Thermo Fisher Scientific Inc

-0.93 (-0.23%)

N/A
WAT Waters Corporation

-6.06 (-1.71%)

N/A

ETFs Containing DHR

AILG 6.99 % 0.00 %

N/A

N/A
PINK Simplify Exchange Traded .. 5.86 % 0.00 %

-0.25 (0.34%)

USD 0.13B
LIFE-U:CA Evolve Global Healthcare .. 5.53 % 0.00 %

N/A

N/A
ZWHC:CA BMO Covered Call Health C.. 4.69 % 0.00 %

-0.15 (0.34%)

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.49 % 0.00 %

+0.11 (+0.34%)

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.34 % 0.00 %

-0.03 (0.34%)

N/A
WHCS:SW iShares MSCI World Health.. 4.21 % 0.00 %

N/A

N/A
YALL God Bless America ETF 4.17 % 0.00 %

+0.09 (+0.34%)

N/A
PRCS Parnassus Core Select ETF 4.14 % 0.00 %

+0.08 (+0.34%)

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.11 % 0.00 %

-0.10 (0.34%)

N/A
CBUF:F iShares V Public Limited .. 4.06 % 0.00 %

+0.04 (+0.34%)

N/A
SANE 3.95 % 0.00 %

N/A

N/A
BCHP EGSHARES BLUE CHIP ETF EG.. 3.49 % 0.00 %

-0.93 (0.34%)

USD 0.12B
XUHC:SW 3.16 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.06 % 0.00 %

+0.08 (+0.34%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.06 % 0.00 %

+8.75 (+0.34%)

N/A
CNEQ The Alger ETF Trust 2.83 % 0.00 %

-0.13 (0.34%)

N/A
INNO 2.76 % 0.00 %

N/A

N/A
BKDV BNY Mellon ETF Trust II 2.62 % 0.00 %

-0.01 (0.34%)

USD 0.29B
USRI:LSE 2.50 % 0.00 %

N/A

N/A
UPVLD:SW 2.35 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.30 % 0.00 %

-0.02 (0.34%)

N/A
XMLH:F Legal & General Ucits Etf.. 1.94 % 0.00 %

-0.12 (0.34%)

N/A
WEBD:XETRA AMUNDI MSCI USA SRI Clima.. 1.92 % 0.00 %

-0.16 (0.34%)

N/A
HYLG 1.44 % 0.00 %

N/A

N/A
LESW:LSE 1.38 % 0.00 %

N/A

N/A
WSRI:LSE 1.30 % 0.00 %

N/A

N/A
WELB:XETRA Amundi MSCI ACWI SRI PAB .. 1.08 % 0.00 %

-0.06 (0.34%)

N/A
RAVI FlexShares Ready Access V.. 0.86 % 0.25 %

+0.04 (+0.34%)

USD 1.26B
CWW.A:CA 0.00 % 1.49 %

N/A

N/A
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.43 (+0.34%)

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+0.09 (+0.34%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
JMIN 0.00 % 0.12 %

N/A

N/A
EVSTC 0.00 % 0.00 %

N/A

N/A
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

N/A

CAD 0.05B
LS:CA 0.00 % 2.21 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.28 (+0.34%)

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+0.43 (+0.34%)

N/A
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

-0.12 (0.34%)

CAD 0.22B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+3.13 (+0.34%)

N/A
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.12 (+0.34%)

N/A
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.20 (+0.34%)

N/A
EMWE:F BNP Paribas Easy - MSCI W.. 0.00 % 0.00 %

-0.24 (0.34%)

N/A
GNAR:F 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.03 (+0.34%)

N/A
XAMB:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.49 (0.34%)

N/A
DXSF:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

+0.09 (+0.34%)

USD 0.08B
EWRD:XETRA 0.00 % 0.00 %

N/A

N/A
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.05 (+0.34%)

N/A
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.25 (+0.34%)

N/A
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.24 (+0.34%)

N/A
NUSA:CA NBI Active U.S. Equity ET.. 0.00 % 0.00 %

-0.25 (0.34%)

CAD 0.06B
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

-0.03 (0.34%)

N/A
XOUT GraniteShares XOUT U.S. L.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.02% 42% F 12% F
Dividend Return 0.14% 43% F 3% F
Total Return -16.89% 42% F 12% F
Trailing 12 Months  
Capital Gain -24.64% 42% F 12% F
Dividend Return 0.45% 43% F 6% D-
Total Return -24.19% 42% F 11% F
Trailing 5 Years  
Capital Gain 28.95% 64% D 50% F
Dividend Return 3.05% 40% F 6% D-
Total Return 32.00% 55% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain 1.15% 33% F 42% F
Dividend Return 1.52% 33% F 32% F
Total Return 0.37% 43% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 25.56% 50% F 37% F
Risk Adjusted Return 5.94% 33% F 28% F
Market Capitalization 54.15B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.10 50% 16%
Price/Book Ratio 2.69 50% 32%
Price / Cash Flow Ratio 20.99 13% 16%
Price/Free Cash Flow Ratio 21.15 25% 15%
Management Effectiveness  
Return on Equity 7.22% 50% 48%
Return on Invested Capital 5.99% 50% 48%
Return on Assets 3.93% 25% 66%
Debt to Equity Ratio 31.29% 88% 72%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.